|
CCDC50 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.46549439250521E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.88178419700125E-16 |
| Normal-vs-Stage2 |
2.303000E-03 |
| Normal-vs-Stage3 |
4.13369999999746E-05 |
| Normal-vs-Stage4 |
8.0496000000041E-05 |
| Stage1-vs-Stage2 |
6.085000E-01 |
| Stage1-vs-Stage3 |
9.056800E-01 |
| Stage1-vs-Stage4 |
1.734480E-02 |
| Stage2-vs-Stage3 |
7.574200E-01 |
| Stage2-vs-Stage4 |
4.148400E-01 |
| Stage3-vs-Stage4 |
1.656840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.44009282066327E-15 |
| Normal-vs-AfricanAmerican |
1.212280E-02 |
| Normal-vs-Asian |
7.324000E-02 |
| Caucasian-vs-AfricanAmerican |
3.899300E-03 |
| Caucasian-vs-Asian |
7.140400E-01 |
| AfricanAmerican-vs-Asian |
1.115020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.29679616939416E-11 |
| Normal-vs-Female |
4.5423997896421E-11 |
| Male-vs-Female |
3.076200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.966500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(61-80Yrs) |
4.03440000296129E-08 |
| Normal-vs-Age(81-100Yrs) |
7.721600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.463800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.472800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.213600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.915600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.659600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.446000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.194800E-04 |
| Normal-vs-Grade 2 |
3.5527136788005E-15 |
| Normal-vs-Grade 3 |
5.16309994758046E-10 |
| Normal-vs-Grade 4 |
4.543500E-03 |
| Grade 1-vs-Grade 2 |
3.566000E-01 |
| Grade 1-vs-Grade 3 |
2.014100E-02 |
| Grade 1-vs-Grade 4 |
2.821600E-03 |
| Grade 2-vs-Grade 3 |
6.959300E-03 |
| Grade 2-vs-Grade 4 |
1.758910E-04 |
| Grade 3-vs-Grade 4 |
6.053700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.55440000004781E-06 |
| ccA subtype-vs-ccB subtype |
6.892000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.19886347913234E-13 |
| Normal-vs-N1 |
1.345840E-01 |
| N0-vs-N1 |
3.943800E-01 |
|
|
